Limitation of Tat-associated transcriptional processivity in HIV- infected PBMC

Virology

Volumn 257, Issue 2, 1999, Pages 397-405

  Adams, Melanie ^a   Wong, Christine ^a   Wang, Dan ^a   Romeo, Joseph ^a  

^a SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSACTIVATOR PROTEIN; VIRUS RNA;

ARTICLE; CELL ACTIVATION; CELL CULTURE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS LATENCY; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033541971     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9647     Document Type: Article

References (43)

1. Adams M., Sharmeen L., Kimpton J., Romeo J. M., Garcia J. V., Peterlin B. M., Groudine M., Emerman M. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc. Natl. Acad. Sci. USA. 91:1994;3862-3866.
2. Bagasra O., Seshamma T., Oakes J. W., Pomerantz R. J. Frequency of cells positive for HIV-1 sequences assessed by in situ polymerase chain reaction. AIDS. 1993;7-10.
3. Bandres J. C., Ratner L. Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. J. Virol. 68:1994;3243-3249.
4. Baur A. S., Sawai E. T., Dazin P., Fantl W. J., Cheng M. C., Peterlin B. M. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity. 1:1994;373-384.
5. Butera S. T., Roberts B. D., Lam L., Hodge T., Folks T. M. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J. Virol. 68:1994;2726-2730.
6. Cavert W., Notermans D. W., Staskus K., Wietgrefe S. W., Zupancic M., Gebhard K., Henry K., Zhang Z. Q., Mills R., McDade H., Schuwirth C. M., Goudsmit J., Danner S. A., Haase A. T. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science. 276:1997;960-964.
7. Chun T. W., Carruth L., Finzi D., Shen X., DiGiuseppe J. A., Taylor H., Hermankova M., Chadwick K., Margolick J., Quinn T. C., Kuo Y. H., Brookmeyer R., Zeiger M. A., Barditch C. P., Siliciano R. F. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387:1997a;183-188.
8. Chun T. W., Finzi D., Margolick J., Chadwick K., Schwartz D., Siliciano R. F. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency. Nat. Med. 1:1995;1284-1290.
9. Chun T. W., Stuyver L., Mizell S. B., Ehler L. A., Mican J. A., Baseler M., Lloyd A. L., Nowak M. A., Fauci A. S. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA. 94:1997b;13193-13197.
10. Cujec T. P., Okamoto H., Fujinaga K., Meyer J., Chamberlin H., Morgan D. O., Peterlin B. M. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:1997;2645-2657.
11. Cullen B. R. HIV-1 auxiliary proteins: Making connections in a dying cell. Cell. 93:1998;685-692.
12. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner R. K., Haase A. T. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 362:1993;359-362.
13. Emiliani S., Fischle W., Ott M., Van L. C., Amella C. A., Verdin E. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line. J. Virol. 72:1998;1666-1670.
14. Emiliani S., Van L. C., Fischle W., Paras P. J., Ott M., Brady J., Verdin E. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc. Natl. Acad. Sci. USA. 93:1996;6377-6381.
15. Finzi D., Hermankova M., Pierson T., Carruth L. M., Buck C., Chaisson R. E., Quinn T. C., Chadwick K., Margolick J., Brookmeyer R., Gallant J., Markowitz M., Ho D. D., Richman D. D., Siliciano R. F. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 278:1997;1295-1300.
16. Finzi D., Silliciano R. F. Viral dynamics in HIV-1 infection. Cell. 93:1998;665-671.
17. Grossman Z., Feinberg M. B., Paul W. E. Multiple modes of cellular activation and virus transmission in HIV infection: A role for chronically and latently infected cells in sustaining viral replication. Proc. Natl. Acad. Sci. USA. 95:1998;6314-6319.
18. Herrmann C. H., Carroll R. G., Wei P., Jones K. A., Rice A. P. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines. J. Virol. 72:1998;9881-9888.
19. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
20. Kao S. Y., Calman A. F., Luciw P. A., Peterlin B. M. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature. 330:1987;489-493.
21. Kim S. Y., Byrn R., Groopman J., Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression. J. Virol. 63:1989;3708-3713.
22. Kinoshita S., Chen B. K., Kaneshima H., Nolan G. P. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell. 95:1998;595-604.
23. Lee T. H., Sunzeri F. J., Tobler L. H., Williams B. G., Busch M. P. Quantitative assessment of HIV-1 DNA load by coamplification of HIV-1 gag and HLA-DQ-alpha genes. AIDS. 5:1991;683-691.
24. +. AIDS Res. Hum. Retroviruses. 5:1989;253-255.
25. +. Ann. Intern. Med. 126:1997;946-954.
26. Mellors J. W., Rinaldo C. J., Gupta P., White R. M., Todd J. A., Kingsley L. A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 272:1996;1167-1170.
27. Meyerhans A., Cheynier R., Albert J., Seth M., Kwok S., Sninsky J., Morfeldt M. L., Asjo B., Wain H. S. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell. 58:1989;901-910.
28. Meyers, J. Korber, B. Wain-Hobson, S. Smith, R. F. Pavlakis, G. N. E. 1993, Human Retroviruses and AIDS, HIV Sequence Database Compendium, Los Alamos National Laboratory, Los Alamos, NM.
29. Nabel G., Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature. 326:1987;711-713.
30. Pantaleo G., Graziosi C., Demarest J. F., Butini L., Montroni M., Fox C. H., Orenstein J. M., Kotler D. P., Fauci A. S. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 362:1993;355-358.
31. Perelson A. S., Neumann A. U., Markowitz M., Leonard J. M., Ho D. D. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science. 271:1996;1582-1586.
32. Piatak M. J., Luk K. C., Williams B., Lifson J. D. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. BioTechniques. 14:1993;70-81.
33. Pomerantz R. J., Trono D., Feinberg M. B., Baltimore D. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency. Cell. 61:1990;1271-1276.
34. Sabino E., Cheng M. C., Mayer A. An individual with a high prevalence of a tat-defective provirus in peripheral blood. AIDS Res. Hum. Retroviruses. 9:1993;1265-1268.
35. Sabino E., Pan L. Z., Cheng M. C., Mayer A. Comparison of in vivo plasma and peripheral blood mononuclear cell HIV-1 quasi-species to short-term tissue culture isolates: An analysis of tat and C2-V3 env regions. AIDS. 8:1994;901-909.
36. Saksela K. HIV-1 Nef and host cell protein kinases. Frontiers Biosci. 1997;606-618.
37. Saksela K., Cheng G., Baltimore D. Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14:1995;484-491.
38. Toth C. R., Hostutler R. F., Baldwin A. J., Bender T. P. Members of the nuclear factor kappa B family transactivate the murine c-myb gene. J. Biol. Chem. 270:1995;7661-7671.
39. Wei P., Garber M. E., Fang S. M., Fischer W. H., Jones K. A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462.
40. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:1995;117-122.
41. Wong J. K., Hezareh M., Gunthard H. F., Havlir D. V., Ignacio C. C., Spina C. A., Richman D. D. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 278:1997;1291-1295.
42. Xu L., Meng Y., Wallen R., DePinho R. A. Loss of transcriptional attenuation in N-myc is associated with progression towards a more malignant phenotype. Oncogene. 11:1995;1865-1872.
43. Zack J. A., Arrigo S. J., Weitsman S. R., Go A. S., Haislip A., Chen I. S. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell. 61:1990;213-222.